GLP-1
GLP-1 users risk losing 25-35% of weight loss as muscle without adequate protein intake. Here's the evidence-based protein…
GLP-1 medications cause 25-30% of weight loss to come from lean muscle. Research-backed strategies including protein prioritization, resistance…
Learn how to track and integrate critical health data while using GLP-1 receptor agonists like semaglutide or tirzepatide…
Learn evidence-based strategies to preserve muscle while taking semaglutide through protein prioritization, strategic training, and optimized nutrition timing.
Insurance denies GLP-1 coverage often—but 40-60% of denials reverse on appeal with proper documentation. This guide covers the…
GLP-1 medications suppress appetite and accelerate fat loss, but research shows they create micronutrient deficiencies that threaten muscle,…
Evidence-based strength training protocols for semaglutide users: preserve lean muscle during weight loss with targeted resistance training and…
Medicare covers GLP-1 for diabetes but not weight loss in 2025. Learn current coverage rules, appeal strategies, and…
Research shows 50% of weight loss returns within 6 months of stopping Ozempic — but structured nutrition and…
Tirzepatide produces 10-15% greater weight loss than semaglutide in head-to-head clinical trials, but both excel when combined with…